Lymphoma treatment in Istanbul, Turkey
Lymphoma is cancer of the lymphatic system, and the subtype drives everything — Hodgkin lymphoma and the many non-Hodgkin subtypes are treated differently. The mainstay is combination chemotherapy, with radiation for some early-stage or bulky disease, immunotherapy and targeted drugs such as rituximab, and stem cell transplant or CAR T-cell therapy for selected relapsed cases. Many lymphomas — including Hodgkin — are highly treatable and often curable, while slow-growing types may simply be watched. Istanbul hospitals offer this full pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
Structure of a lymph node — the afferent and efferent lymphatic vessels, capsule, sinus and nodules, the tissue involved in lymphomas.
SEER Training Modules, U.S. National Cancer Institute — public domain (opens in a new tab) ↗What lymphoma is
The U.S. National Cancer Institute describes lymphoma as cancer that begins in the lymphatic system, in the white blood cells called lymphocytes. The NCI groups it into two broad categories: Hodgkin lymphoma, defined by the presence of Reed-Sternberg cells, and non-Hodgkin lymphoma (NHL), which is not one disease but a large family of subtypes ranging from indolent (slow-growing) to aggressive. The subtype is what determines the whole treatment plan.
Diagnosis rests on a lymph node biopsy examined under the microscope, with immunophenotyping to identify the exact subtype, and the extent of disease is worked out with imaging that often includes a PET-CT scan, plus a bone marrow examination in some cases. Because symptoms such as painless swollen lymph nodes, fevers, night sweats and weight loss can be vague, the NCI notes lymphoma is sometimes found only after other causes are ruled out. Browse the wider cancer types hub for related diagnoses.
Treatment options
The modalities the NCI lists for lymphoma, and an honest note on each:
- Chemotherapy. Combination chemotherapy regimens are the mainstay for most lymphomas, and many — including Hodgkin lymphoma — are highly treatable and often curable with them. Cost scales with the number of cycles. See chemotherapy in Turkey.
- Radiation therapy. Radiation is used for some early-stage or bulky disease, often after chemotherapy, and whether it applies depends on your subtype, stage and where the disease sits. See radiotherapy in Turkey.
- Immunotherapy and targeted therapy. Monoclonal antibodies such as rituximab are added to chemotherapy for many B-cell lymphomas; checkpoint-inhibitor immunotherapy is used for some Hodgkin lymphoma; and CAR T-cell therapy is an option for certain relapsed or refractory aggressive B-cell NHL.
- Stem cell transplant. A stem cell (bone marrow) transplant is used for selected relapsed cases, where high-dose chemotherapy is followed by an infusion of stem cells to rebuild the marrow. It is not a first-line treatment for most patients.
One honest caveat runs through all of this: indolent non-Hodgkin lymphoma may be actively watched rather than treated right away, and the exact subtype from your biopsy — not a template — decides which path fits. See how these modalities work in general on the treatments & technology hub.
What it costs
There is no single lymphoma price, because the cost is driven by the subtype, the number of chemotherapy cycles, whether radiation is used, and whether targeted drugs, immunotherapy, CAR T-cell therapy or a stem cell transplantare added — those advanced therapies are priced per course and can dominate the total. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line. You pay the hospital directly, never us. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling hematologists or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose hematology and medical-oncology subspecialty fits your lymphoma subtype, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one diagnosis family within the broader cancer treatment in Istanbul pillar. If you want your own reports read first, a free second opinion organizes and verifies your biopsy and imaging into a plain-language case file in your language before you decide whether to travel.
Related cancers
Check everything here — us included
Common questions
Can I get lymphoma treatment in Turkey?
Yes. Istanbul hospitals provide the full lymphoma pathway the U.S. National Cancer Institute describes — a lymph node biopsy and immunophenotyping to name the exact subtype, staging with imaging that often includes PET-CT, and then combination chemotherapy, radiation for some early-stage or bulky disease, immunotherapy and targeted drugs such as rituximab, and stem cell transplant or CAR T-cell therapy for selected relapsed cases. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. Because the subtype changes the whole plan, the honest first step is a free case review of your biopsy and imaging before you travel.
Hodgkin vs non-Hodgkin lymphoma — how does treatment differ?
The category, and then the exact subtype, drives everything. Per the NCI, Hodgkin lymphoma is defined by Reed-Sternberg cells and is one of the more curable cancers, usually treated with combination chemotherapy sometimes followed by radiation, with checkpoint-inhibitor immunotherapy for some relapsed cases. Non-Hodgkin lymphoma is a large group of subtypes: aggressive B-cell types are often treated with chemotherapy plus the antibody rituximab, while indolent (slow-growing) types may be watched for a time before any treatment starts. Only a biopsy with immunophenotyping can say which you have, so this is general information, not a treatment recommendation.
When is CAR T-cell therapy or a stem cell transplant used for lymphoma?
Mostly for lymphoma that comes back or does not respond to first-line treatment. The NCI describes stem cell (bone marrow) transplant for selected relapsed cases, where high-dose chemotherapy is followed by an infusion of stem cells to rebuild the marrow. CAR T-cell therapy — in which your own T cells are re-engineered to attack the cancer — is an option for certain relapsed or refractory aggressive B-cell non-Hodgkin lymphomas. Both are complex, subspecialized treatments that are not used up front for most patients. Whether either fits your case depends on your subtype and prior treatment, which a case review will help clarify.
How much does lymphoma treatment cost in Istanbul?
There is no single figure, because the cost is driven by the subtype, the number of chemotherapy cycles, whether radiation is used, and whether targeted drugs, immunotherapy, CAR T-cell therapy or a stem cell transplant are added — those advanced therapies are priced per course and can dominate the total. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. You pay the hospital directly, never us. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your biopsy and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.